45 related articles for article (PubMed ID: 33583629)
1. Patterns of recurrence following definitive chemoradiation for patients with proximal esophageal cancer.
de Vos-Geelen J; Geurts SME; Nieuwenhuijzen GAP; Voncken FEM; Bogers JA; Braam PM; Muijs CT; de Jong MA; Kasperts N; Rozema T; Blom GJ; Bouwense SAW; Valkenburg-van Iersel LBJ; Jeene PM; Hoebers FJP; Tjan-Heijnen VCG
Eur J Surg Oncol; 2021 Aug; 47(8):2016-2022. PubMed ID: 33583629
[TBL] [Abstract][Full Text] [Related]
2. Clinical response to chemoradiotherapy in esophageal carcinoma is associated with survival and benefit of consolidation chemotherapy.
Zhao Z; Zhang Y; Wang X; Geng X; Zhu L; Li M
Cancer Med; 2020 Aug; 9(16):5881-5888. PubMed ID: 32627960
[TBL] [Abstract][Full Text] [Related]
3. Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer.
Han J; Zakeri K; Raab G; Hesse J; Shamseddine A; Chen L; Yu Y; Kang JJ; McBride SM; Riaz N; Tsai CJ; Gelblum D; Sherman EJ; Wong RJ; Michel L; Lee NY
Head Neck; 2023 Sep; 45(9):2207-2216. PubMed ID: 37439286
[TBL] [Abstract][Full Text] [Related]
4. Local efficacy and survival outcome of salvage endoscopic therapy for local recurrent lesions after definitive chemoradiotherapy for esophageal cancer.
Hatogai K; Yano T; Kojima T; Onozawa M; Fujii S; Daiko H; Yoda Y; Hombu T; Doi T; Kaneko K; Ohtsu A
Radiat Oncol; 2016 Feb; 11():31. PubMed ID: 26922374
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes after non-curative endoscopic resection for esophageal squamous cell carcinoma followed by additional chemoradiotherapy.
Cho H; Abe S; Nonaka S; Suzuki H; Yoshinaga S; Okuma K; Yamamoto S; Daiko H; Kato K; Sekine S; Boku N; Saito Y
Dis Esophagus; 2024 Apr; 37(5):. PubMed ID: 38266034
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy.
Cox S; Hurt C; Grenader T; Mukherjee S; Bridgewater J; Crosby T
Radiother Oncol; 2017 Oct; 125(1):154-159. PubMed ID: 28893415
[TBL] [Abstract][Full Text] [Related]
7. Surgical vs nonsurgical treatment for esophageal squamous cell carcinoma in patients older than 70 years: a propensity score matching analysis.
Li K; Li C; Nie X; He W; Du K; Liu K; Wang C; Li J; Han Y; Peng L; Wang Q; Leng X
J Gastrointest Surg; 2024 May; 28(5):611-620. PubMed ID: 38704198
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of chemoradiation therapy compared with chemotherapy for esophageal carcinoma: An updated meta-analysis of randomized controlled trials.
Liu J; Xue L; Zhen F; Luo J
Medicine (Baltimore); 2017 Nov; 96(47):e8929. PubMed ID: 29382033
[TBL] [Abstract][Full Text] [Related]
9. Locoregional Recurrence of Esophageal Cancer Treated with Curative Intent Local Salvage Therapy: A Single Center Experience.
Grou-Boileau F; Tankel J; Nevo Y; Najmeh S; Spicer J; Cools-Lartigue J; Mueller C; Ferri L
J Gastrointest Cancer; 2023 Dec; 54(4):1292-1299. PubMed ID: 36988820
[TBL] [Abstract][Full Text] [Related]
10. Salvage chemoradiation therapy for recurrence after radical surgery or palliative surgery in esophageal cancer patients: a prospective, multicenter clinical trial protocol.
Chang X; Deng L; Ni W; Li C; Han W; Gao LR; Wang S; Zhou Z; Chen D; Feng Q; Liang J; Bi N; Lv J; Gao S; Mao Y; Xue Q; Xiao Z
BMC Cancer; 2020 Sep; 20(1):877. PubMed ID: 32928136
[TBL] [Abstract][Full Text] [Related]
11. Definitive radiotherapy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: A multicenter retrospective study (KROG 21-10).
Song JY; Moon SH; Suh YG; Kim JH; Oh D; Noh JM; Jeong JU; Cho IJ; Kang MK; Kim JH; Kim YS; Kim HJ; Park WY; Kim BH; Kim HJ
Radiother Oncol; 2023 Dec; 189():109936. PubMed ID: 37783290
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic resection for residual oesophageal neoplasia after definitive chemoradiotherapy.
Honing J; Koch AD; Siersema PD; Spaander M
Best Pract Res Clin Gastroenterol; 2024 Feb; 68():101885. PubMed ID: 38522883
[TBL] [Abstract][Full Text] [Related]
13. A phase III randomized controlled trial comparing local field with additional prophylactic irradiation in chemoradiotherapy for clinical-T1bN0M0 esophageal cancer: ARMADILLO trial (JCOG1904).
Sasaki K; Nomura M; Kato K; Sakanaka K; Ito Y; Kadota T; Machida R; Kataoka T; Minashi K; Tsubosa Y; Kajiwara T; Fukuda H; Takeuchi H; Mizowaki T; Nishimura Y; Kitagawa Y
Jpn J Clin Oncol; 2024 Jan; 54(1):103-107. PubMed ID: 37801434
[TBL] [Abstract][Full Text] [Related]
14. Induction immunochemotherapy followed by radiotherapy for patients with unresectable locally advanced or metastatic esophageal cancer: A propensity score-matched analysis.
Deng W; Chang X; Dong X; Zhao Y; Yang D; Jiang L; Shi A; Yu H; Yu R; Xiao Z; Wang W
Int Immunopharmacol; 2023 Nov; 124(Pt B):110955. PubMed ID: 37725845
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic ultrasound for structured surveillance after curative treatment of esophageal cancer.
Bohle W; Nowack L; Schaudt A; Koeninger J; Zoller WG; Albert JG
Z Gastroenterol; 2024 May; 62(5):737-746. PubMed ID: 38198802
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes.
Samuels SE; Stenmark MH; Lee JY; McHugh JB; Hayman JA; Orringer MB; Urba SG; Sun L; Xie C; Kong FM; Cuneo KC
Adv Radiat Oncol; 2017; 2(3):308-315. PubMed ID: 29114597
[TBL] [Abstract][Full Text] [Related]
17. A Case of Recurrent Esophageal Cancer Treated with Concurrent Chemoradiation Therapy in Pregnancy.
Yamada K; Chigusa Y; Nomura M; Sakanaka K; Nakamura M; Yano S; Tsunoda S; Kondoh E; Mandai M
Case Rep Obstet Gynecol; 2018; 2018():1280582. PubMed ID: 30627462
[TBL] [Abstract][Full Text] [Related]
18. RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung Cancer.
Radonic T; Geurts-Giele WRR; Samsom KG; Roemen GMJM; von der Thüsen JH; Thunnissen E; Meijssen IC; Sleddens HFBM; Dinjens WNM; Boelens MC; Weijers K; Speel EJM; Finn SP; O'Brien C; van Wezel T; Cohen D; Monkhorst K; Roepman P; Dubbink HJ
J Thorac Oncol; 2021 May; 16(5):798-806. PubMed ID: 33588111
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of Interval Distant Metastases After Neoadjuvant Chemoradiotherapy for Esophageal Cancer.
Kroese TE; Dijksterhuis WPM; van Rossum PSN; Verhoeven RHA; Mook S; Haj Mohammad N; Hulshof MCCM; van Berge Henegouwen MI; van Oijen MGH; Ruurda JP; van Laarhoven HWM; van Hillegersberg R
Ann Thorac Surg; 2022 Feb; 113(2):482-490. PubMed ID: 33610543
[TBL] [Abstract][Full Text] [Related]
20. Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients.
Huber V; Di Guardo L; Lalli L; Giardiello D; Cova A; Squarcina P; Frati P; Di Giacomo AM; Pilla L; Tazzari M; Camisaschi C; Arienti F; Castelli C; Rodolfo M; Beretta V; Di Nicola M; Maio M; Del Vecchio M; de Braud F; Mariani L; Rivoltini L
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
